Search - tctmd.com

Displaying 241 - 260 of 1893

Sort: Relevancy | Date

Both COVID-19 and Vaccination Raise the Risk of POTS

News Daily News

Both COVID-19 and Vaccination Raise the Risk of POTS

December 12, 2022

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

December 06, 2022

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

News Daily News

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

Yael L. Maxwell

December 05, 2022

TCTMD’s Top 10 Most Popular Stories for November 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

December 01, 2022

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

News Daily News

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

December 01, 2022

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

News Conference News PCR London Valves 2022

TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story

November 30, 2022

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

November 23, 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

November 09, 2022

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

News Conference News AHA 2022

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Yael L. Maxwell

November 07, 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

November 06, 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

November 06, 2022

Apixaban Again Linked to Less Bleeding in AF Patients

News Daily News

Apixaban Again Linked to Less Bleeding in AF Patients

Michael O'Riordan

October 31, 2022

COVID Vaccine Thrombosis, Thrombocytopenia Risks Clarified in International Study

News Daily News

COVID Vaccine Thrombosis, Thrombocytopenia Risks Clarified in International Study

October 28, 2022

Lauren Gray Gilstrap, Heart Failure and Transplant Expert, Dies at 38

News Daily News

Lauren Gray Gilstrap, Heart Failure and Transplant Expert, Dies at 38

Yael L. Maxwell

October 27, 2022

Drop in Kawasaki Disease During COVID-19 Provides Clues to Pathogenesis

News Daily News

Drop in Kawasaki Disease During COVID-19 Provides Clues to Pathogenesis

October 21, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

‘Ridiculous’ System Has Many Calling for an Interventional Cardiology Match

News Features

‘Ridiculous’ System Has Many Calling for an Interventional Cardiology Match

Yael L. Maxwell

October 19, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.